Keywords: Ranbaxy, Daiichi Sankyo, China subsidiary, HNG Chembio

India’s Ranbaxy pulls out of Chinese JV subsidiary with HNG Chembio

Article | 04 January 2010

Print This

India’s largest drugmaker Ranbaxy Laboratories, which is majority (64%) owned by Japanese drug major Daiichi Sankyo, is to sell its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in